Passage Bio (NASDAQ:PASG) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Passage Bio (PASG) operate in?

Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Passage Bio Stock (NASDAQ: PASG) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	34.00 / 246.75K
Day Range	- - -
52 Wk Range	0.45 - 1.79
Market Cap	$34.76M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	3.19%
Days to Cover	6.65

Recent News

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.

Avi Kapoor

Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities

Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated virus (AAV)-delivery gene therapy for frontotemporal dementia (FTD) with

Vandana Singh

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	34.00 / 246.75K
Day Range	- - -
52 Wk Range	0.45 - 1.79
Market Cap	$34.76M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	3.19%
Days to Cover	6.65

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Passage Bio (PASG) stock?

You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.

View our list of the best stock brokerages

Who are Passage Bio (PASG) competitors?

Other companies in Passage Bio’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA) and Intensity Therapeutics (NASDAQ:INTS).

What is the forecast, or price target, for Passage Bio (PASG) stock?

Passage Bio has a consensus price target of $7.71.

What is the current price for Passage Bio (PASG)?

The stock price for Passage Bio (NASDAQ: PASG) is $0.5628 last updated November 21, 2024 at 7:25 PM EST.

Does Passage Bio (PASG) pay a dividend?

There are no upcoming dividends for Passage Bio.

When is Passage Bio (NASDAQ:PASG) reporting earnings?

Passage Bio’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Passage Bio (PASG) going to split?

There is no upcoming split for Passage Bio.

What sector and industry does Passage Bio (PASG) operate in?

Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Passage Bio

Passage Bio (PASG) Forecast